ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • T and B Lymphocyte Dynamics after Genetically-Modified Pig-To-Baboon Kidney Xenotransplantation with an Anti-CD40mAb-Based Immunosuppressive Regimen

    A. Jagdale1, H. Iwase1, H. Nguyen1, T. Yamamoto1, D. Ayares2, D. Anderson1, D. Eckhoff1, D. Cooper1, H. Hara1

  • T Cell Activation by Allogeneic EVs and Allogeneic MHC Cross-Dressed Cells In Vitro and In Vivo

    A. Prunevieille1, B. Gonzalez-Nolasco1, G. Benichou1, N. Mooney2, A. Colleen3

  • T Cell Dysfunction as Measured by Impaired Antigen Response is Associated with Infection and Frailty in Kidney Transplant Recipients

    J. Schaenman, M. Rossetti, V. Groysberg, G. Sunga, E. Liang, S. Bunnapradist, E. Reed

  • T Cell Hyporesponsiveness in Kidney Transplant Recipients is Associated with Urinary Tract Infections and Age of Kidney Transplant: Implications for Allograft Nephropathy

    A. Assounga, S. Omarjee

  • T Cells from Highly Sensitized Kidney Transplant Patients Display Distinct TCR Repertoires

    S. Negi1, M. Li1, A. Rutman2, S. Paraskevas1, C. Polychronakos1, J. Tchervenkov1

  • T Follicular Regulatory Cell Deficiency Enhances Secondary T Follicular Helper Cell Responses after Transplantation

    E. S. Crichton, S. Zeng, I. Badell

  • T-cell Receptor Deep Sequencing to Distinguish Autoimmune Recurrence from Allograft Rejection in Liver Transplant Patients with Autoimmune Liver Disease

    K. J. Yang1, M. Martinez2, B. Shonts1, C. A. Parks1, A. Z. Obradovic1, T. M. Savage1, E. Spyrou1, S. Lau1, M. I. Colquhoun1, K. Rodgers1, E. Verna3, S. M. Coley4, S. Yang1, Y. Shen5, M. Sykes1

  • Tacrolimus Concentrations Are Associated with Measures of Body Composition in Adult Kidney Transplant Recipients

    K. S. Parker1, B. Derstine2, J. Sullivan2, S. Wang2, A. Mazurek1, D. Cron1, S. Waits1

  • Taking it to the Max: Extremely Low LDL May Provide Benefit for Prevention of Cardiac Allograft Vasculopathy

    R. Lee1, E. J. Henricksen1, Y. Moayedi2, K. Y. Feng3, J. Han3, W. Yang4, R. Imai1, J. J. Teuteberg4, K. K. Khush4

  • Taking Liver Transplant to “The Friendly Skies”: A Novel Pilot Program Using Commercial Flights and Ride-Sharing Apps to Minimize Dry-Run Expenses and Expand Potential Donors

    G. J. McKenna, N. Onaca, H. Fernandez, E. Martinez, A. Gupta, A. Wall, J. Bayer, R. Ruiz, G. Testa

  • Taking on Pediatric Liver Tumors – Beyond Hepatoblastoma

    U. Ekong, N. Yazigi, K. Khan, S. Kaufman, J. Guerra, R. Girlanda, J. Hawksworth, A. Kroemer, C. Matsumoto, T. Fishbein

  • Takotsubo Cardiomyopathy Following Liver Transplantation: A Single Center Experience

    O. Shamaa1, S. Jafri1, M. Shamaa2, K. Brown1, D. Venkat1

  • Targeted Urine Metabolomics for Monitoring Renal Allograft Injury and Immunosuppression

    T. Sigdel, A. Schroeder, J. Y. Yang, R. Sarwal, J. Liberto, M. Sarwal

  • Targeting CD4+ T Cell Metabolism Prolongs Graft Survival Age-Specifically

    Y. Nian, J. Iske, K. Minami, R. Maenosono, T. Heinbokel, A. Elkhal, S. G. Tullius

  • Targeting CD62 – CD162 Signaling with a Soluble Form of a Tandem-PSGL-1 in a Murine Model of Hindlimb Transplantation

    K. Kadono1, F. Messner2, Y. Guo2, B. Oh2, G. Brandacher2, J. W. Kupiec-Weglinski1

  • Targeting Th17: TIGIT as a Key Regulator of Tregs/Th17 Cells in Belatacept Resistant Rejection

    C. R. Hartigan, M. Wagener, M. L. Ford

  • Targeting the CD40/CD40L Axis in Sensitized Nonhuman Primate Allotransplantation

    Z. W. Fitch, R. Schmitz, M. Manook, A. Y. Choi, J. Yoon, J. Kwun, S. J. Knechtle

  • Technology Access, Use, and Intent among Kidney Transplant Candidates Vulnerable to Health Disparities

    S. Smith1, M. Keller2, R. Seibert3, L. Kayler1

  • Teduglutide Therapy in Real World Setting is Efficacious in Reducing Complications in Short Bowel Syndrome

    T. Ashraf1, V. Mendiratta2, M. Abu Ghanimeh2, H. Abdulla1, S. Nagai3, N. Beltran3, S. Jafri2

  • Tele Health Utilization in Kidney Transplantation Clinic

    S. Wattanatorn, S. Udomkarnjananun, N. Townamchai, T. Thammathiwat, N. Mahatanan, Y. Avihingsanon, K. Praditpornsilpa

  • Telehealth Medicine: A Novel Tool to Make Living Donation Simple and Financially Neutral

    A. Yadav, M. Cantarin Martinez, P. Singh

  • Temporal Trends in Depression and Anxiety in Potential Live Kidney Donors

    A. Ravi, D. Bakhai, E. Clifton, S. Norman, A. Naik, Y. Lu, R. Parasuraman, M. Doshi

  • Temporal Trends in the Incidence and Impact of Biliary Complications Following Liver Transplantation

    K. R. Jackson1, K. Lentine2, M. Schnitzler2, Z. Zhang2, H. Xiao2, J. Motter1, D. Axelrod3, D. Segev1

  • Temporal Trends in the Incidence and Impact of Infections Following Kidney Transplantation

    K. R. Jackson, J. Motter, R. Avery, W. Werbel, J. Garonzik-Wang, D. Segev

  • Temporal Trends in Utilization and Outcomes of DCD Livers for Liver Transplantation in the United States

    K. R. Jackson, J. Motter, A. Massie, B. Philosophe, J. Garonzik-Wang, D. Segev

  • Temporal Trends in Utilization and Outcomes of Sclerotic Donor Kidneys in the United States

    J. D. Motter, K. R. Jackson, J. J. Long, A. B. Massie, N. M. Desai, D. L. Segev, J. M. Garonzik-Wang

  • Ten Year Results of a Single Center Study of Rabbit Anti-Thymocyte Globulin Compared to Alemtuzumab Induction in Simultaneous Pancreas-Kidney Transplantation

    V. Gurram, K. Gurung, G. Orlando, A. Farney, J. Rogers, C. Jay, W. Doares, S. Kaczmorski, A. Reeves-Daniel, A. Mena-Gutierrez, M. Gautreaux, R. Stratta

  • Tertiary Lymphoid Organs in Renal Chronic Allograft Rejection

    K. Abou Daya, D. Zhao, K. Biery, M. Oberbarnscheidt

  • Testing Deceased Organ Donors for Infections: An Organ Procurement Organization (OPO) Survey

    N. M. Theodoropoulos1, P. Chin-Hong2, M. Greenwald3, M. G. Ison4

  • Tetramethylpyrazine Activated Pparγ in Resuscitating the Liver Graft Donatedafter Cardiac Death

    F. Zhen, F. Lin, Z. Lihua, L. Wenjin, X. Yan, C. Yong, Y. Qifa

  • Textbook Outcome as a Composite Quality Metric in Kidney Transplantation

    J. L. Han, A. J. Logan, J. M. Sneddon, G. L. Brock, K. W. Washburn, A. D. Schenk

  • Textbook Outcome: Definition and Analysis of a Novel Quality Measure in Kidney Transplantation

    S. E. Halpern1, D. Moris2, B. I. Shaw2, L. M. McElroy2, M. J. Ellis3, D. Sudan2, S. J. Knechtle2, B. H. Collins2, A. S. Barbas2

  • TGF-b Induced Myeloid-Derived Suppressor Cells Prevent Transplatation Rejection by Promoting Immune Tolerance

    P. Cao, Z. Sun, J. Zhang, F. Zhang, W. Wang

  • TGR5/Cathepsin E Signaling Regulates Macrophage Innate Immune Activation in the Sterile Inflammatory Liver Injury

    H. Zhou, S. Zhou, Q. Wang, Z. Rao, X. Wang, L. Lu

  • Th17 Cell Inhibition in a Costimulation Blockade Based Regimen for Vascularized Composite Allotransplantation Using A Non-Human Primate Model

    D. P. Moris, A. Atia, M. Rae, M. Song, L. Stempora, F. Leopardi, K. Williams, J. Kwun, W. Parker, A. Cardones, A. D. Kirk, L. C. Cendales

  • Thalidomide and Dexamethasone Combinatorial Treatment Induces Tolerogenic Signals by Systemic Immunomodulation of T Cells and Dendritic Cells

    B. Kim1, E. Kim2, J. Kim2, H. Choi3, H. Lee2, J. Lee4, M. Kim4, Y. Kim4, K. Huh4

  • The 1-Year Incremental Costs of Delayed Graft Function (DGF) in Commercially Insured Kidney Transplant Patients Under 65

    T. Mayne1, F. Corvino2, A. Dillon2, W. Wang2, S. Mohan3

  • The 1st Year Posttransplant Course Reliably Predicts Kidney Graft Survival up to 15 Years Using a Machine Learning-Based Modeling Approach

    W. Gwinner, M. Gietzelt, R. Hanna, A. A. Khalifa, M. Hallensleben, M. Marschollek, H. Haller, J. H. Braesen, I. Scheffner

  • The Accuracy of the ICD-10 Diagnostic Codes for Kidney Transplant Rejection and Failure

    D. Massicotte-Azarniouch1, M. Sood2, D. Fergusson3, M. Chassé4, A. Tinmouth5, G. Knoll2

  • The Addition of Splenectomy to Simultaneous Liver Kidney Transplantation Improves Class II DSA Clearance in Sensitized Patients

    V. Fleetwood, D. Aufhauser, C. Papageorge, K. Janek, L. Hidalgo, B. Welch, R. Redfield, J. Mezrich

  • The Application of Electron Microscope Examination in Evaluation of Donor Liver Quality in Liver Transplantation

    M. Chen1, X. Lin2, Z. Chen1, M. Han1, W. Ju1, X. He1

  • The Application of Hypothermic Machine Perfusion in Kidney Transplantation from Delay Graft Function High Risk Donor

    Y. Li, X. Hu, G. Chen, C. Ding, W. Xue

  • The Art Rather Than the Science of Non-HLA Antibody Mediated Rejection in Heart Transplantation: A Single Center Experience

    A. Alam, S. Mckean, R. Patel, V. Darst, H. Zafar, C. Guerrero, M. Askar, T. Sam, S. Hall

  • The Association between Alloimmunity and De Novo Glomerulonephritis Post Kidney Transplantation

    P. Khairallah, J. Kamal, E. Vasilescu, I. Batal, G. Dube

  • The Association between Donor Hypothermia and Allograft Outcomes in Liver and Kidney Transplantation

    S. Karhadkar, B. Kaplunov, A. Di Carlo

  • The Association between Infection and Important Clinical Outcomes in Acute-On-Chronic Liver Patients Admitted to ICU: A Single Center Cohort Analysis

    M. Kim1, A. Pawlowski2, R. G. Wunderink3, D. P. Ladner4, C. J. Karvellas5

  • The Association between Preoperative Hemodynamics and Right Ventricular Failure Following Implantation of Left Ventricular Assist Device

    D. Bhakta1, A. Alam2, J. S. van Zyl2, H. Zafar2, A. Aasim2, D. M. Meyer2, J. Felius2, S. Hall2, D. Wencker2

  • The Association between Timed-Up-and-Go Test and Montreal Cognitive Assessment on Outcomes of Renal Transplant Candidates

    K. Bozhilov, L. Wong

  • The Association of Body Weight Gain/Change and Hepatocellular Carcinoma Recurrence after Liver Transplant

    O. Ahmed1, M. Sauer1, N. Vachharajani1, S. H. Chang2, Y. Park2, A. S. Khan1, W. C. Chapman1, M. B. Doyle1

  • The Banff Classification of Antibody-Mediated Rejection in Kidney Allografts: Comparison of Predictive Performance for Allograft Failure in Previous and Current Editions

    J. Callemeyn1, H. Ameye1, M. Coemans1, A. Senev2, E. Lerut3, B. Sprangers1, D. Kuypers1, M. Emonds2, M. Naesens1

  • The Case Against Race: Proportion of Minorities Does Not Explain Low DSA Donation Performance

    R. Lynch, K. Ross, D. Goldberg

  • The Centennial Allograft – Can an Organ Function for Over 100 Years in 2 Different Individuals?

    A. Gruessner, J. Renz, S. Saggi, R. Gruessner

  • The Centers for Medicare and Medicaid Services’ Proposed Metrics for Recertification of Organ Procurement Organizations: Evaluation by the Scientific Registry of Transplant Recipients

    J. Snyder1, D. Musgrove1, D. Zaun1, A. Wey1, N. Salkowski1, J. Rosendale2, A. Israni1, R. Hirose3, B. Kasiske1

  • The Challenge of Selecting an Induction Agent: A Dual Regimen for Medically High-Risk Kidney Recipients

    R. Craig-Schapiro, B. Magaoay, R. Grover, S. Sultan, M. Aull, S. Kapur

  • The Changes of Transaminases, Lactate Dehydrogenase and pH Levels During Normothermic Liver Preservation Correlate with Early Allograft Dysfunction

    C. Bogensperger

  • The Clinical Impact of HCV D+/r- Kidney Transplantation

    S. Meade1, M. A. Simpson2, E. D. Walshe2, M. E. Akoad2, F. D. Gordon2

  • The Clinical Relevance of cPRA in 0-ABDRDQ Mismatched Kidney Transplants

    J. H. Lan1, D. Chang1, M. Kadatz1, J. Gill1, H. M. Gebel2, J. S. Gill1

  • The Clinical Significance of C1q+ Antibodies in Pediatric Kidney Transplant Recipients

    N. Hayde1, S. Solomon2, A. Colovai1

  • The Clinical Usefulness of Preformed C1q-Binding Donor-Specific Antibodies in Kidney Transplantation

    S. Lee, E. Ko, B. Chung, C. Yang

  • The Composite Molecular and Cellular Instability Score Identifies the Sub-Phenotypes of Histologically Stable Kidney Transplants

    D. Rychkov

  • The Development of an Innovative Training Pathway for Robotic Assisted Renal Transplant Program

    H. Pournik1, J. Castillo2, V. Brown2, J. Collins2, C. Haisch2, D. Leeser2

  • The Economic Impact of HCV D+/R- Kidney Transplantation

    S. Meade1, M. A. Simpson2, E. D. Walshe1, M. E. Akoad2, F. D. Gordon2

  • The Economic Impact of National Standardization of Virtual Crossmatch Usage in Kidney Transplantation

    J. E. Stanton1, L. M. Rebellato2, H. Pournik1, J. E. Tuttle-Newhall1, H. Jones1, W. Irish1, D. B. Leeser1

  • The Effect of African American Race on Morbidity for Donors Undergoing Living Kidney Donation: A Single Center Study

    D. R. White, F. Desrosiers, S. Sultan, R. Craig-Schapiro, J. del Pizzo, S. Kapur, A. Watkins

  • The Effect of ANG-3777 on Hepatocyte Growth Factor Receptor C-MET Signaling

    L. Paka, I. D. Goldberg

  • The Effect of B Cell Depletion Therapies on Preformed Xenoantibodies in Transplant Recipient

    S. Yeh1, N. A. Wilson2, A. Djamali2, R. Redfield3

  • The Effect of Desensitization Therapy on Sex Disparity in Living Kidney Transplantation

    Y. Kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

  • The Effect of Donor Transaminase Levels on Graft Survival Following Liver Transplantation: An OPTN Database Analysis

    I. A. Ziogas1, P. N. Martins2, S. P. Alexopoulos1, L. K. Matsuoka1, S. K. Geevarghese1, L. D. Gorden1, S. J. Karp1, J. D. Perkins3, M. I. Montenovo1

  • The Effect of Ex Vivo Preservation and Regulatory T Cells on the Development of Transplant Arteriosclerosis in a Humanized Mouse Model

    A. Knoefel, T. Siemeni, F. Ius, W. Sommer, J. Salman, I. Tudorache, A. Haverich, C. Falk, G. Warnecke

  • The Effect of Expanding Utilization of Living Donor Liver Transplantation tn the United States

    K. N. Wanis1, A. Sarvet1, M. J. Stensrud1, B. Al-Judaibi2, K. Tomiyama3, R. Hernandez-Alejandro3

  • The Effect of Human Thrombomodulin on Thrombotic Complications in Life Supporting Pig-to-Baboon Cardiac Xenotransplantation

    C. E. Goerlich1, A. Singh1, D. Kaczorowski1, M. Abdullah1, B. Lewis1, I. Tatarov1, A. Hershfeld1, T. Zhang1, P. Odonkor1, E. Strauss1, B. Williams1, D. Ayares2, M. Mohiuddin1

  • The Effect of Intravenous Acetaminophen on Opioid Use in Laparoscopic Donor Nephrectomy Patients

    C. Makosiej, A. Eisenhart

  • The Effect of Pulsatile Pump Perfusion on Hepatitis C Viremia and Transmission in Kidney Transplantation: A Prospective Pilot Study

    R. Forbes1, B. Concepcion1, D. Clapper2, B. Dubray1, A. Miller2, D. Shaffer1, K. Johnson2

  • The Effect of Undernutrition and Immunosuppression on Cytomegalovirus Specific T Cell Responses

    E. David1, M. Zhu2, W. Parker2, N. MacIver1, A. D. Kirk2, E. T. Chambers1

  • The Effect of UNOS Donor Policy Change on Distance from Recipient Hospital and the Effects on Mortality in Heart Transplantation

    P. Kingsford1, J. P. Li1, C. J. Lum2, A. D. Salimbangon3, G. S. Liu4, R. R. Chand5, P. Banankhah1, P. A. Genyk1, D. Vucicevic1, K. Pandya1, J. Rahman1, M. Fong1, L. Grazette1, A. Kiankhooy1, J. Nattiv1, S. Hashmi1, S. B. Nuno1, J. Pizula1, D. J. Miklin1, A. E. Lee1, K. Yang1, S. Shah1, A. S. Vaidya1, A. M. Wolfson6, E. C. DePasquale1

  • The Effect of UNOS Donor Policy Change on Ischemic Time and the Effects on Mortality in Heart Transplantation

    A. Lee1, K. Yang1, G. Liu1, C. Lum2, A. D. Salimbangon3, R. R. Chand4, P. Banankhah1, P. Genyk1, P. Kingsford1, J. Li1, J. Li1, D. Vucicevic5, K. Pandya1, J. Rahman1, M. Fong1, L. Grazette1, A. Kiankhooy1, J. [email protected]1, S. Hashmi1, A. Gong1, J. Pizula1, D. Miklin1, S. Shah1, A. Vaidya1, A. Wolfson6, E. Depasquale1

  • The Effects of DGF after Deceased Donor Renal Transplantation Differ by KDPI

    M. Molinari1, W. Chang1, D. Jorgensen2, C. Wu3, S. Hariharan3

  • The Effects of Rivaroxaban and Apixaban on Tacrolimus Pharmacokinetics

    A. C. Scheibner1, C. Franco-Martinez1, E. Kincaide1, R. Hall1, C. Long2

  • The Efficacy and Safety of Ischemia-Free Liver Transplantation (IFLT) in the Treatment of End-Stage Liver Disease in a Prospective, Randomized, Controlled Trial: A Report of the First 25 Cases

    X. He, Z. Guo, Q. Zhao, C. Huang, W. Ju, D. Wang, M. Chen, L. Wu, Y. Ma, Y. Chen, A. Hu, X. Zhu

  • The Efficacy of Spheroidal Hepatocyte in Hepatocyte Transplantation

    K. Shibuya, M. Watanabe, R. Kanazawa, Y. Ganchiku, R. Goto, A. Taketomi

  • The Eplet-Mismatch Landscape in Kidney Patients and Deceased Donors in British Columbia

    J. Tran1, O. Gunther2, J. Lan1, M. Kadatz1, R. Sapir-Pichhadze3, P. A. Keown1

  • The Evolution and Impact of ABMR Histology and Transplant Glomerulopathy in the Presence or Absence of HLA-DSA

    M. Coemans1, A. Senev1, G. Verbeke2, M. Emonds1, M. Naesens1

  • The Evolution of Renal Graft Failure Risk: The Power of the Proximal

    T. Mayne1, S. Mohan2

  • The Experience of 1000 Cases of Hand Assisted Laparoscopic Donor Nephrectomy for Living Donor Kidney Transplantation

    T. Hiramitsu1, T. Tomosugi1, K. Futamura1, M. Okada1, N. Goto1, S. Narumi1, K. Uchida2, Y. Watarai1

  • The FcγRIIIa-158 VV Genotype Increased the Risk of Post-Transplant Lymphoproliferative Disorder in T-Cell Depleted Kidney Transplant Recipients

    P. Gatault1, L. Lajoie1, J. Stojanova2, P. Marquet2, G. Thibault1

  • The Fibrinogen-Like Protein 2 Molecule Influences the Development of Thymic Regulatory T-Cells

    C. Lam1, S. Moshkelgosha1, G. A. Levy2, A. Chruscinski3, S. C. Juvet4

  • The Financial Concerns of Non-Directed (Altruistic) Living Kidney Donors – How Can We Improve the Donation Process?

    A. Maghen1, G. Mendoza1, G. B. Vargas1, S. E. Connor1, S. Nassiri1, L. Kwan1, E. L. Wood1, J. Lalezari1, S. Friedman1, A. D. Waterman2, S. George3, S. L. Maliski4, J. L. Veale1

  • The Forgiven Disease: Outcomes of Lung Transplantation in Two HIV-Infected Patients

    S. Biswas Roy1, M. T. Olson2, M. A. Smith1, R. M. Bremner1, R. Walia1, A. Arjuna1

  • The Frequency of De Novo DSA in the Years Following Heart Transplantation

    A. Shen, J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, K. Nishihara, L. Czer, F. Esmailian, J. A. Kobashigawa

  • The Gut Microbiota Stimulates Dendritic Cells for Immune Modulation

    V. Saxena, W. Piao, L. Hittle, L. Li, T. Simon, C. Palusckievicz, Y. Xiong, T. Zhang, M. Shirkey, E. F. Mongodin, J. S. Bromberg

  • The Heart of the Matter: The Impact of the 2018 Heart Allocation Policy at a Single Organ Procurement Organization

    A. J. Boyer, J. B. Nave, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski

  • The Histological Picture of Indication Biopsies in the First Days after Renal Transplantation

    E. Van Loon, M. Coemans, A. Senev, D. Kuypers, M. Emonds, M. Naesens

  • The Impact of a Positive Crossmatch on KAS Patients and Organs

    J. Lee1, K. Sjöholm2, C. Kjellman2, T. Lorant2, L. Winstedt2, V. Nigro2, K. M. Roupé2, Å. Schiött2, A. Runstrom2, S. Taranto3, T. Baker3, D. Stewart3

  • The Impact of Cold Ischaemia Time on Living Donor Kidney Transplantation Outcomes

    S. C. van de Laar1, M. Robb2, R. Hogg2, V. Papalois1, F. J. Dor1

  • The Impact of Deceased Donor Maintenance on the Incidence of Delayed Kidney Allograft Function

    S. Costa1, F. Barroso1, C. Oliveira1, E. Daher1, P. Fernandes1, L. Andrade2, R. Esmeraldo3, T. Sandes-Freitas1

  • The Impact of DSA Screening in Stable Kidney Transplant Recipients in the 1st Year Post-Transplant

    A. Sharma1, D. Jorgensen2, R. Mehta1, P. Sood1, C. Wu1, C. M. Puttarajappa1, A. Tevar1, S. Hariharan1

  • The Impact of Epitope Mismatch Load and Shared Targeting Epitopes between De Novo Donor Specific Antibody (DSA) and Non-DSA Third Party HLA Antibody on Lung Transplantation Outcomes

    A. Zhang1, D. Good1, D. Thomas1, J. Allen1, K. McCurry2, M. Budev2

  • The Impact of HLA-DQ Molecular Mismatches on De Novo Occurrence of Donor-Specific Anti-HLA Antibodies after Kidney Transplantation: An Observational Cohort Study

    A. Senev1, M. Coemans1, V. Van Sandt2, E. Van Loon1, J. Callemeyn1, B. Sprangers1, D. Kuypers1, M. Emonds1, M. Naesens1

  • The Impact of Increased Visceral Fat in Kidney Transplant Recipients

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

  • The Impact of Initial Alpha-Fetoprotein >100 but <1,000 ng/mL and Pre-Transplant alpha-Fetoprotein Reduction on Outcomes after Liver Transplant in Patients with Hepatocellular Carcinoma

    M. L. Goldman1, K. Zhou2, J. L. Dodge1, F. Yao1, N. Mehta1

  • The Impact of Multi-Organ Transplant Allocation Priority on Wait-Listed Isolated Kidney Transplant Candidates

    S. Westphal1, E. Langewisch1, A. Robinson2, A. Wilk2, T. Plumb1, R. Mullane1, S. Merani1, A. Hoffman1, A. Maskin1, C. Miles1

  • The Impact of Non-Directed Anonymous Live Liver Donors on the Number of Children on the Waitlist at a Single Pediatric Liver Transplant Center

    D. Yoeli1, M. A. Adams1, M. E. Wachs1, S. S. Sundaram2, R. A. Choudhury1, K. D. Conzen1, J. R. Burton3, E. A. Pomfret1, W. E. Jackson3

  • The Impact of Occult Graft Fibrosis on Clinical Outcomes in Human Liver Transplant Recipients

    H. Hirao1, T. Ito1, B. V. Naini1, K. Nakamura2, S. Kageyama1, K. Kadono1, H. Kojima1, K. J. Dery1, S. Younan1, F. M. Kaldas1, R. W. Busuttil1, J. W. Kupiec-Weglinski1

  • The Impact of Pre-Existing and New Onset Diabetes on Healthcare Utilization Following Kidney Transplantation

    D. Taber, N. Pilch, N. Patel, H. Perkins, K. Foster, C. Perez, F. Bartlett, A. Posadas, H. Meadows, K. Soliman, V. Rao, M. Casey, V. Rohan, J. McGillicuddy, S. Nadig, D. Dubay

  • The Impact of Preoperative Glucose Intolerance and Hypertension on the Living Kidney Donors

    T. Hiramitsu1, T. Tomosugi1, K. Futamura1, M. Okada1, N. Goto1, S. Narumi1, K. Uchida2, Y. Watarai1

  • The Impact of Purposeful Reductions in Immunosuppression on Clinical Outcomes in Kidney Transplantation

    K. Foster, H. Perkins, N. Patel, C. Perez, N. Pilch, H. Meadows, F. Bartlett, V. Rao, M. Casey, M. Posadas Salas, K. Soliman, J. McGillicuddy, D. Taber

  • The Impact of Sirolimus on Weight Gain Post Heart Transplant

    S. M. Gore, C. E. Raphael, K. Mara, C. Arendt, A. L. Clavell, S. A. Bernard

  • The Impact of the New Heart Allocation Policy on the Treatment of United States Adult Heart Transplant Candidates

    K. Chung1, A. S. Anderson2, M. Siegler1, M. M. Churpek3, W. Parker1

  • The Impact of Thy1 Expression of Fibroblast for Chronic Lung Allograft Dysfunction

    A. Hata1, Y. Guo1, D. Li1, Z. Mei1, A. Manafi1, A. Banerjee1, B. Mahgoub1, T. H. Barker2, A. S. Krupnick1

  • The Impact of Transportation Innovation for Human Organs: Surgical Perspectives and Implications

    T. Talaie, S. Niederhaus, E. Villalonga, J. Bromberg, J. Scalea

  • The Impact Of Weight Reduction Surgery And Morbid Obesity On Renal Function After Transplantation

    S. Negi1, N. Saberi1, P. Bouchard2, a. Andalib2, M. Cantarovich1, S. Paraskevas1, J. Tchervenkov1

  • The Importance of Annual Medicare Part D Plan Evaluation

    L. Potter1, E. Garrity2

  • The Importance of Annual Medicare Part D Plan Evaluation in Heart Transplantation

    L. M. Lourenco

  • The Importance of Caveolin-1 Immunohistochemical Staining for BK Nephropathy Seen after Kidney Transplantation

    E. Arpali1, E. Sunnetcioglu2, Y. Özlük2, A. Turkmen3, F. S. Oğuz1

  • The Incidence, Clinical Characteristics and Prophylactic Strategy of Invasive Fungal Infections in Lung Transplantation

    L. Zhao1, W. Chen1, L. Guo1, L. Jing1, C. Liang1, J. Chen1, C. Wang2

  • The Inflammatory Response in the Context of Tissue Injury: Roles of Tyro3, Axl, and Mer (TAM) Receptors in Liver Ischemia/Reperfusion Injury

    J. Zhang, M. Ni, D. Jin, H. Zhang, R. Busuttil, J. Kupiec-Weglinski, Y. Zhai

  • The Influence of Donor Kidney to Recipient Body Weight Ratio on Long-Term Outcomes of Living-Donor Kidney Transplantation

    N. Sato, Y. Kakuta, T. Kanzawa, K. Unagami, M. Okumi, H. Ishida, K. Tanabe

  • The Influence of Spirituality and Other Motivations on Potential Kidney Living Donors’ Decisions to Donate by Race/Ethnicity

    A. Waterman1, G. H. Kim1, Y. Cui2, O. N. Ranasinghe1, J. L. Beaumont2, D. Adey3, U. Reddy4, B. Campbell5, F. L. Weng6

  • The Influence of the Donor Kidney Weight to Recipient Body Weight Ratio on Long-Term Renal Graft Outcomes

    S. Yang1, J. Lee1, Y. Jung2, B. Kim3, M. Kim1, S. Kim1, Y. Kim1, K. Huh1

  • The Learning Curve for Pure Laparoscopic Robotic Kidney Transplantation: An Analysis of Outcomes of the First 80 Consecutive Cases at a High-Volume Transplant Center

    F. Tinney Jr.1, J. Stracke2, T. Ivanics1, A. Elsabbagh1, J. Denny1, D. Kim1, L. Malinzak1, A. Yoshida1

  • The Level of Plasm Donor-Derived Cell-Free DNA in Kidney Transplant Patients with Severe Pneumonia

    L. Liu1, H. Liu2, F. Liu2, L. Shu2, L. Peng1

  • The Link between Waitlist Mortality and Access to Transplant, an Imaginative Reality

    R. Batra1, D. Mulligan1, D. Haakinson1, S. Noreen2, D. Stewart2, G. Gan3, Y. Deng3, S. Kulkarni1

  • The Liver Outcome Monitoring Registry Consortium: Data and Preliminary Outcome Results

    J. Case1, S. Kurian1, B. Barrick1, A. Robinson2, M. Prentice2, C. Marsh1

  • The Liver Outcome Monitoring Registry Donor Risk Index: A New Measure of Deceased Donor Liver Quality

    S. Kurian1, J. Case1, A. Robinson2, B. Barrick1, M. Prentice2, C. Marsh1

  • The Liver Protects All? Donor Specific Antibody Formation in Heart-Liver Transplant Recipients

    A. W. Rogers1, T. N. Eagar2, C. Pham1, J. Krisl1, B. J. Pierce1, M. Moaddab1, R. Ghobrial3, B. Trachtenberg4, A. Bhimaraj4, A. O. Gaber3

  • The Liver Regenerative Effect of Substance P after Major Hepatectomy in Rat Models

    H. Ahn1, Y. Kim1, O. Kwon2

  • The Living Donor Collective Pilot Evaluations of Living Kidney Donor Candidates at 10 Programs

    B. Kasiske, M. Conboy, Y. Ahn, A. Israni, J. Snyder

  • The Living Donor Collective Pilot Evaluations of Living Liver Donor Candidates at 6 Programs

    B. Kasiske, M. Conboy, Y. Ahn, A. Israni, J. Snyder

  • The Long Term Impact of Metabolic Syndrome on Post-Donation in Living Kidney Donors

    C. Chen, T. Yu, Y. Chuang, S. Tsai, M. Wu

  • The Mechanism How the Transplanted Islets Engraft Into White Adipose Tissue

    N. Sakata, G. Yoshimatsu, T. Tanaka, R. Kawakami, S. Kodama

  • The Natural History of Waitlist Candidates in the United States

    A. Massie1, D. Segev2

  • The Negative Impact of Inherent Oxidative Stress in Marginal Lungs on Ex Vivo Lung Perfusion

    K. Noda1, B. J. Philips1, M. Velayutham2, T. Harano1, P. Reck dos Santos1, S. Shiva2, P. G. Sanchez1

  • The New UK National Kidney Allocation Scheme with Maximized ‘D4/R4’ Kidney Transplants: Appropriate Donor to Recipient Matching or System Overstretch?

    R. Pearson, E. Murray, P. Thompson, P. Mark, M. Clancy, J. Asher

  • The Next Era of Living Kidney Donation for Renal Transplantation: Virtual Postoperative Follow-Up

    S. Allen, D. Taber, C. Perez, S. N. Nadig, V. Rohan

  • The Noninvasive Urinary Sediment Double Immunostaining Test Predicts BK Polyomavirus Nephropathy in Kidney Transplant Recipients

    G. Huang1, X. Chen1, S. Yang1, X. Hou2, H. Yang3, C. Wang1

  • The Oncological Optimal Tacrolimus Target Level after Liver Transplant for Hepatocellular Carcinoma

    K. Sasaki1, J. McVey1, D. Firl2, Y. Inaba3, C. D. Kwon1, K. Hashimoto1, F. Aucejo1

  • The Outcomes of Pancreas Transplantation from Pediatric Donors: A Single Center Experience

    J. Choi, Y. Ko, H. Kwon, S. Shin, Y. Kim, D. Han

  • The Perioperative Coagulation Profile of Hepatocellular Carcinoma During Liver Transplantation Compared to Patients with Non-Malignant Disease: A Cause or Association for Decreased Blood Product Utilization During Liver Transplantation?

    H. B. Moore, E. Pomfret, J. Pomposelli, C. Walker, R. Choudhury, H. Yaffe, M. Wachs, T. Bak, K. Conzen, M. Adams, T. Pshak, T. L. Nydam

  • The Plasma DdcfDNA Level Associates with the Pathological Characteristics in Renal Allograft

    R. Wang, J. Shen, J. Wu, J. Chen

  • The Pleural Cavity, A Novel and Clinically Relevant Site for Pancreatic Islet Transplantation

    Q. Yuan1, K. Lee1, C. Rickert1, S. Hong1, E. Acheampong1, E. Szuter1, Y. Xu2, K. Deng1, N. Feeney1, Q. Fu1, G. Huai1, J. Lei1, I. Rosales1, P. Russell1, J. Madsen1, R. Colvin1, A. Alessandrini1, J. Markmann1, -. Q.Y. and K.L.3, -. A.A. and J.F.M.4

  • The Potential Significance of ABO Genotyping for Donor Selection in Kidney Transplantation

    Y. Zhou1, W. Deng1, Y. Wang1, N. Cui1, Y. Wu1, J. Xu1, S. Fu1, L. Xiao1, H. Liu1, F. Xiong2, Y. Miao1

  • The Prevalence of Preemptive Transplantation at a Large Volume Kidney Transplant Center

    T. Menser1, M. J. Hobeika2, S. G. Yi2, T. Nisar1, A. Gaber2

  • The Pro-Inflammatory Profile of Alcoholic Patients Increases Risk for Ischemia-Reperfusion Injury During Orthotopic Liver Transplantation

    A. Q. Terry1, R. A. Sosa1, M. Rossetti1, F. Li1, J. Nevarez-Mejia1, B. V. Naini1, F. M. Kaldas2, V. M. Groysberg1, S. M. Younan2, R. W. Busuttil2, D. W. Gjertson1, J. W. Kupiec-Weglinski3, E. F. Reed1

  • The Prognostic Impacts of Recipient Gender in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma

    K. Sasaki, M. Sanghvi, M. Fujiki, T. Diago Uso, B. Eghtesad, C. Quintini, C. MIller, K. Hashimoto, C. D. Kwon, F. Aucejo

  • The Protective Effect of Hypothermic Oxygenated Machine Perfusion (HOPE) Onresuscitating Steatotic Liver and its Underlying Mechanism

    F. Lin1, F. Zhen1, X. Yan1, L. Wenjin1, Y. Qifa2

  • The Ratio between Naïve and Memory B Cells is Associated with Development of Early Donor-Specific Antibodies within the First Month after Lung Transplantation

    A. Hitz1, R. Bellmàs Sanz1, F. Ius2, J. Kühne1, B. Wiegmann2, W. Sommer2, J. Salman2, T. Siemeni2, C. Kühn2, M. Avsar2, A. Haverich2, I. Tudorache2, G. Warnecke2, C. Falk1

  • The Relationship Between Frailty and Performance Status in Patients with Cirrhosis Awaiting Liver Transplantation

    C. Q. Xu1, F. Yao2, Y. Mohamad2, R. Wong2, D. Kent2, S. Seetharaman2, Y. Srisengfa2, J. C. Lai2

  • The Reperfusion Response in Plasma of Combined Heart/ Lung Transplanted Patients is Guided by Heart-Associated Cytokine Patterns on Contrast to the Ischemic Injury in Perfusion Solutions Following a Lung-Associated Pattern

    C. Falk1, J. Kühne2, L. Radomsky2, F. Wandrer2, B. Wiegmann3, N. Ledwoch2, J. Keil2, K. Beushausen2, F. Ius3, W. Sommer3, S. Rojas-Hernandez3, I. Tudorache3, A. Haverich3, G. Warnecke3

  • The Requirement of Thymic Irradiation for Induction of Mixed Chimerism and Renal Allograft Tolerance in Non-Human Primates

    T. Hirose1, H. Sasaki1, T. Oura1, D. Ma1, A. Dehnadi1, R. B. Colvin2, I. Rosales2, A. B. Cosimi1, T. Kawai1

  • The Risks Associated with Blood Transfusions in Kidney Transplant Recipients: A Retrospective Cohort Study Using Health Administrative Data

    D. Massicotte-Azarniouch1, M. Sood2, D. Fergusson3, M. Chassé4, A. Tinmouth5, G. Knoll6

  • The Role and Impact of Transplant Pharmacist Evaluation in a Pre-Kidney Transplant Clinic

    B. Valdepenas, D. Choi, J. Benken, M. Campara

  • The Role of Antigen Presentation in B Regulatory Cell Function

    A. Cuenca1, N. Feeney2, K. Deng2, Q. Fu2, G. Huai2, C. Rickert2, K. Lee2, J. Markmann2

  • The Role of Ceria-Nanoparticles in Renal Ischemia Reperfusion Injury Models in Rats

    C. T. Chung, H. Ko, H. Kim, H. Mo, A. Han, S. Min, J. Ha

  • The Role of Complement-Split Products as Biomarkers for Acute Antibody-Mediated Rejection of Kidney Allografts

    B. G. Abu Jawdeh1, B. Campos-Naciff1, K. Harrison1, K. Meganathan1, A. Kumar2, M. Anand1, A. Govil1, E. S. Woodle1, B. P. Dixon3

  • The Role of CXCL16/CXCR6 in Mediating Macrophage Chemotaxis and M1 Macrophage Polarization in Murine Renal Ischemia Reperfusion Injury

    W. Zhang1, X. Zhang2, G. Tu2, C. Yang1, G. Qi1, M. Xu1, T. Zhu1

  • The Role of Galectin-1 and Basement Membrane Remodeling in Kidney Antibody-Mediated Rejection

    S. Clotet-Freixas1, C. McEvoy1, I. Batruch2, M. Kotlyar3, C. Pastrello3, J. Van1, M. Arambewela1, A. Boshart1, S. Farkona1, A. Bozovic4, V. Kulasingam4, P. Chen1, I. Jurisica3, A. Chruscinski1, R. John4, A. Konvalinka5

  • The Role of mTOR Inhibitors on Cardiovascular Aging in Renal Transplanted Patients with Chronic Graft Dysfunction

    G. Castellano1, B. Infante1, P. Pontrelli1, R. Franzin1, F. Rascio1, C. Prisciandaro2, L. Gesualdo1, N. Coviello3, G. Grandaliano3, G. Stallone3

  • The Role of Th17 Polarized T Regulatory Cells in Intestinal Transplant Rejection

    L. Belyayev1, M. Sadat2, J. Kang2, K. Loh2, A. Duttargi2, S. Moturi2, K. Khan2, J. Hawksworth2, C. Matsumoto2, T. Fishbein2, A. Kroemer2

  • The Role of the Molecular Microscope to Guide Therapy for T-Cell Mediated Rejection in Kidney Transplants

    D. Kumar1, M. Demehin1, J. Christensen1, L. Kamal1, I. Moinuddin1, M. Levy1, C. Bhati1, A. King1, H. D. Massey1, P. Halloran2, G. Gupta1

  • The Safety and Effectiveness and of Isoniazid Empirical Prophylaxis Compared to Screening Based Prophylaxis Post Lung Transplantation

    G. B. Korayem1, R. S. Almaghrabi2, N. I. AlSuhaibani1, G. S. AlSwailem1, M. A. AlShammari1, D. A. Aleissa3

  • The Safety and Efficacy of 6-Month Steroid Reduction Strategy after Kidney Transplantation: A Prospective Cohort Study

    J. Bang, C. Oh, S. Lee

  • The Scenario of Delayed Graft Function in Brazil

    T. V. Sandes-Freitas1, M. Mazzali2, R. Manfro3, H. Tedesco-Silva4, L. Andrade5, V. Garcia6, E. Davi-Neto7, R. Esmeraldo8, C. Oliveira9, E. Lasmar10, R. Madeira11, G. Ferreira12, G. Meira13, F. Cavalcanti14, A. Bignelli15, D. Carvalho16, D. Pedroso17, L. Deboni18, A. Silva e Filho19, A. Vicari3, M. Sousa2, .. on behalf of 'DGF multicêntrico' group20

  • The Significance of Donor Gender on Graft Survival and Histological Ischemia Reperfusion Injury in Liver Transplant Patients

    T. Ito, S. Kageyama, K. J. Dery, K. Nakamura, S. M. Younan, M. M. Lu, J. DiNorcia III, V. G. Agoian, H. Yersis, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • The State of Interventional Clinical Trials in Solid Organ Transplant: Insights from a Systematic Analysis of Clinicaltrials.gov

    A. C. Swaminathan1, J. Li1, K. Chiswell1, W. McManigle1, I. O’Doherty2, W. Fitzsimmons3, J. L. Todd1, S. Tibbs4, S. M. Palmer1

  • The Strategy and Utility of Checkpoint Inhibitor Therapy in Patient with Hepatocellular Carcinoma Recurrence Following Liver Transplantation

    L. Jeng, S. Hsu, A. Thorat

  • The Study of Continuous Renal Replacement Therapy Performing in Pre-Retrieval Management of Marginal Criteria Donor Lung: A Retrospective Control Study

    J. Huang1, X. Zheng2, Z. Wang1, M. Huang2, J. Chen1

  • The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is it Time to Split the Difference?

    D. Yoeli1, M. Adams1, R. Choudhury1, T. Nydam1, J. Pomposelli1, J. Goss2, M. Wachs1

  • The Therapeutic Potential of Human Liver-Derived Stem Cells Transplantation in Carbon Tetrachloride-Induced Rat Liver Cirrhotic Model

    S. Lee1, J. Lee2, H. Park2, Y. Kim2, S. Lee1

  • The Time is Now: Improving Waiting Times in Minority Populations

    L. Mendez-Castaner, L. Preczewski, M. Muldoon, A. Harshman, M. Goble, G. Guerra

  • The Transcriptomic Analysis Revealed a Clear Deregulation of the C1QB Gene in Peripheral Blood Mononuclear Cells of Renal Transplant Patients with Chronic Antibody Mediated Rejection

    G. Zaza1, S. Granata1, G. Santoro1, C. Caletti1, P. Pontrelli2, F. Rascio3, M. Rossi1, S. Andrighetto1, G. Grandaliano4

  • The Trend of Non-Utilization and Decline of Hepatitis C Virus Antibody-Positive Deceased Donor Kidneys

    S. Chang1, K. Lentine2, D. Axelrod3, J. Wellen1, M. Wang1, M. A. Schnitzler4, T. Alhamad5

  • The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study

    M. Park1, Y. Gao1, S. Schroeder2, S. Siyahian1, Z. Laszik1, F. Vincenti1

  • The Urine Qisant Score: Non-Invasive, Accurate, Diagnosis and Prediction of Kidney Transplant Rejection

    J. Y. Yang1, R. Sarwal1, T. Sigdel1, I. Damm1, B. Rosenbaum1, J. Liberto1, C. Chan-On1, J. Alberu2, F. Vincenti1, M. M. Sarwal1

  • The Use of Allosure Donor Derived Cell-Free DNA in a Community Based Kidney Transplant Program

    V. Scantlebury, S. Gilibert, C. Sentman, H. Chang-DeGuzman, S. Swanson

  • The Use of Cell-Free MicroRNAs for the Diagnosis of Allograft Rejection in Liver Transplant Recipients Using Standard and Novel Direct Detection Platforms

    T. Kohut1, B. Chang2, J. Wen1, A. Shaked2, B. Keating2

  • The Use of dd-cfDNA as a Predictive Tool for Future Proteinuria

    S. Jordan1, P. Sood2, J. Bromberg3, D. Brennan4

  • The Use of Interviews to Explore the Public Attitudes on the Use of Imminent Death Donation

    P. Moolchandani1, L. Washburn1, M. Goss2, S. Parsons3, R. Brown3, E. Ranova3, R. Ackah1, K. Myer4, R. Wood4, A. Rana1, J. Goss1, T. Galván1

  • The Use of Scribes in Transplant Practice to Achieve Quality Outcomes and Foster Program Development

    M. Debroy, K. Chavin

  • The Value of Pharmacist-Driven Valganciclovir Dosing in Kidney Transplant Recipients in Reducing CMV Infection: A Single Center Experience

    K. D. Belfield1, C. E. Costello2, M. Malinis3

  • Therapeutic Inhibition of Spleen Tyrosine Kinase Decreases Hepatic Damage after Ischemia Reperfusion Injury

    A. Zarrinpar, V. Boominathan, A. Kobayashi, S. Duarte

  • Therapeutic Targeting of Bile Acid Metabolism Ameliorates Liver Ischemia/Reperfusion Injury

    M. Ni1, D. Jin2, T. Lu2, J. Zhang1, R. Busuttil1, J. Kupiec-Weglinski1, J. Zhang2, Y. Zhai1

  • Third and Fourth Kidney Re-Transplants: A 20-Year Single Centre Experience

    O. O. Okidi1, A. Hassan1, S. Bhutani1, A. Summers1, K. Poulton2, C. Fullwood1, D. VanDellen1, J. Worthington2, T. Augustine1

  • Three Year Post Co-Stimulation Blocking Agent (Belatacept) Switch Outcomes of Kidney Transplant Patients Diagnosed with Post-Transplant Thrombotic Microangiopathy

    A. Gamilla-Crudo, S. Hussain, A. Rizvi, R. Ramirez, M. Kueht, H. Stevenson-Lerner, J. Fair, M. Mujtaba

  • Three-Month Results of a Phase 2 Trial Evaluating Clazakizumab in Late Antibody-Mediated Rejection – Early Impact of Interleukin-6 Blockade on Donor-Specific Antibody Levels, Rejection Morphology and Gene Expression

    G. A. Böhmig1, M. Dürr2, B. Jilma3, F. Eskandary1, E. Chong4, S. Schranz3, K. Doberer1, M. Wahrmann1, A. Borski1, H. Regele5, J. Kläger5, R. Reindl-Schwaighofer1, J. Reeve6, K. Budde2, P. F. Halloran6

  • Three-Year Post-Transplant Outcome of Desensitized Mechanical Circulatory Support Patients Awaiting Heart Transplantation

    J. Youn1, R. Cole2, D. Ramzy2, E. Kim1, J. Kobashigawa2, J. Moriguchi2

  • Thymic B Cells: A Means to Control Regulatory Tolerance

    C. LeGuern1, S. Germana1, N. Feeney1, Z. Wang2, N. Tanimine1, C. Huang3, C. Rickert1, J. Markmann1

  • Thymoglobulin (ATG) Induction vs. Campath vs. Simulect in DCD Kidneys in UK; Induction Regimes Play a Role after All

    A. Asderakis1, T. Sabbah1, J. Watkins2, L. Szabó1, D. Elker1, A. M. Ilham1, E. Ablorsu1, M. Stephens1, U. Khalid1, R. Chavez1

  • Thymoglobulin Dose and Incidence of Biopsy Proven Acute Rejections in the Early Post Transplant Period

    K. Shimko, K. Schonder, D. Jorgensen, K. Kalra, A. Cherukuri, R. Mehta, I. Melgarejo, P. Sood, S. Hariharan, R. Mehta

  • Thymoglobulin for Induction Less is Clearly More!

    N. Patel, P. Nicole

  • Thymoglobulin Induction in Kidney Transplant Recipients: A Single Center Experience Comparing 3 Mg/kg vs 5 Mg/kg Cumulative Dosing

    K. Progar1, S. January1, N. Nesselhauf1, J. Hagopian1, A. Malone2

  • TIM-4+ Kupffer Cells Play Homeostatic Roles in Liver Ischemia Reperfusion Injury

    M. Ni1, J. Zhang1, R. Sosa2, S. Kageyama1, R. Busuttil1, R. Elaine2, J. Kupiec-Weglinski1, X. Wang3, Y. Zhai1

  • Time for Change: Assessment of Renal Transplant Artery Stenosis with N.A.T.I.V.E. True-F.I.S.P. and N.A.T.I.V.E. G.R.E

    J. C. Infante1, A. Mattiazzi2, M. Morsi3, G. Guerra2, M. J. Defreitas4, J. Chandar4, L. J. Chen3, G. W. Burke3, J. Figueiro3, G. Ciancio3

  • Time-Trend of Metabolic Risks in Living Kidney Donors in South Korea

    E. Kang1, J. Park1, S. Park1, Y. Kim2, J. Jeong3, J. An4, S. Lee5, S. Kim6, J. Cho7, M. Han8, H. Lee1

  • Time-Zero Histology Correlates with Donor Characteristics but Does Not Predict Short-Term Outcomes in Kidney Transplantation

    S. Raza, G. Agarwal, D. Anderson, M. Deierhoi, H. Fatima, M. Hanaway, J. Locke, P. MacLennan, B. Orandi, C. Young, R. Mannon, M. Seifert

  • Timing of Bariatric Surgery for Obese Kidney Transplant Candidates

    R. A. Choudhury1, D. Yoeli1, G. Hoeltzel2, H. B. Moore1, H. Yaffe1, K. R. Dumon3, N. N. Williams3, P. L. Abt4, K. D. Conzen1, T. Pshak1, P. T. Kennealey1, T. L. Nydam1

  • Timing of Bariatric Surgery for Obese Liver Transplant Candidates

    R. A. Choudhury1, D. Yoeli2, G. Hoeltzel3, H. B. Moore2, H. Yaffe2, K. R. Dumon4, N. N. Williams4, P. L. Abt5, K. D. Conzen2, J. J. Pomposelli2, E. A. Pomfret2, T. L. Nydam2

  • Tissue Resident Memory T Cells in Mouse Renal Transplantation

    K. Abou-Daya1, D. Zhao1, R. Tieu1, R. Rammal2, M. Oberbarnscheidt1, F. Lakkis1

  • Tissue Specificity and the Role of Lymphocytes in Estrogen-Mediated Protection from Renal Ischemia Reperfusion Injury

    P. T. Hernandez, C. S. O'Brien, S. J. Concors, L. N. Krumeich, Z. Wang, G. Ge, W. Hancock, M. H. Levine

  • To Donate or Not to Donate? The Balancing Act of Apol-1 Genetic Testing in Potential Living Kidney Donors of African Descent in Resource Limited Countries

    O. Ekwenna1, C. Okwuonu2, I. Thoms3

  • To Fix or Not to Fix: Kidney Outcomes Requiring Renal Artery Reconstruction Due to Surgical Damage

    J. Figueiro, R. Vianna, W. De Faria, S. Elizabeth, G. Ciancio, G. Guerra

  • To Wait or Not to Wait: The Survival Benefit of Preemptive Kidney Transplantation after Accounting for Lead Time Bias

    S. Yu1, A. Kernodle1, J. Snyder2, J. Garonzik-Wang1, D. Segev1, A. Massie1

  • Tolerant Liver Transplant Patients Have Higher Level of Y RNA Fragments in the Circulation

    C. Kuscu1, A. Wolen1, A. Bajwa1, C. Kuscu1, J. Eason2, B. Ramaswami3, D. Maluf1, G. Mazariegos3, G. Chalasani3, V. Mas1

  • Tonic-Signaling Chimeric Antigen Receptors Drive Exhaustion in Regulatory T Cells

    C. Lamarche1, C. Mackall2, E. Weber3, M. Levings4

  • Torc1 Inhibition Protects Activated Human Regulatory T Cells from Self-Inflicted Damage via Granzyme B

    J. B. Alhaddad, H. Allos, B. S. Al Dulaijan,, S. K. Eskandari, I. Sulkaj, G. Melhem, J. Y. Choi, J. R. Azzi

  • Torque Teno Virus for Risk Stratification of Graft Rejection and Infection in Kidney Transplant Recipients – A Prospective Observational Trial

    K. Doberer, G. Böhmig, E. Puchhammer, G. Bond

  • Torque Teno Virus Level for Risk Stratification of Subclinical Graft Rejection at 12 Months after Kidney Transplantation – An Prospective Observational Cohort Study

    K. Doberer, E. Puchhammer, G. Böhmig, G. Bond

  • Total Pancreatectomy with Islet Autotransplantation in Diabetic and Prediabetic Patients with Intractable Chronic Pancreatitis

    P. J. Bachul1, D. J. Grybowski1, R. Anteby2, L. Basto1, L. Perea1, K. Golab1, L. Wang1, M. Tibudan1, A. Perez-Gutierrez1, M. Komorniczak3, S. Nagpal4, A. Lucander1, P. Borek1, M. Dimitrov1, J. Fung1, J. B. Matthews1, P. Witkowski1

  • Total Penis, Scrotum, and Lower Abdominal Wall Transplant: 18-Month Update

    D. S. Cooney1, C. M. Cooney1, V. Javia1, J. T. Shores1, A. L. Burnett2, T. J. Bivalacqua2, G. Brandacher1, R. J. Redett1

  • Totally Robotic Living Donor Hepatectomy Graft Parenchymal Transection Time

    Y. L. Cheah, J. Kim, C. J. Simon, S. Meade, R. Jenkins, M. E. Akoad

  • TPIAT Outcomes in Diabetic and Non-Diabetic Patients with Chronic Pancreatitis

    M. A. Kanak, P. Saravanan, J. Kalivarathan, G. Hobbs, M. F. Levy

  • Tracking Tregs in a Non-Human Primate Model with Expanded Autologous Treg Infusions In Vivo

    K. Bruestle1, B. Piegari1, H. Sakai1, F. Fredriksson1, D. Ekanayake-Alper1, S. Robertson2, D. Hajosi2, J. Weiner1, A. Iuga3, S. M. Coley3, M. Sykes1, A. Griesemer1

  • Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease after Kidney Transplantation

    M. Raynaud1, O. Aubert1, P. Reese2, M. Naesens3, D. Glotz1, C. Legendre1, S. Jordan4, M. Stegall5, D. Segev6, C. Lefaucheur1, A. Loupy, On behalf of the study NCT034740031

  • Transarterial Chemoembolization and Radio-Embolization are Similarly Efficacious in Achieving Successful Hepatocellular Carcinoma (HCC) Down-Staging: Results from the Multicenter Evaluation of Reduction in Tumor Size Before Liver Transplantation (MERITS-LT) Consortium

    N. Mehta1, J. Guy2, C. Frenette3, P. Tabrizian4, M. Hoteit5, N. Parikh6, T. Ghaziani7, R. Dhanasekaran7, J. L. Dodge1, M. L. Holzner4, S. Florman4, F. Yao1

  • TRANSBIO Study: Clinical Evaluation of Immunobiogram, a Novel In Vitro Diagnostic Immunoassay to Guide Adjustment of Immunosuppressive Therapy in Kidney Transplantation

    J. Pascual1, C. Jiménez2, M. Krajewska3, C. Kotton4, D. Seron5, J. Portolés6, O. Witzke7, S. S. Sorensen8, A. Andrés9, T. Díez10, A. Ortega10, I. Portero10

  • Transcriptome-Based Study of Tim-1- B Cells and Tim-1+ Regulatory B Cells

    Q. Fu, K. Lee, C. G. Rickert, G. Huai, K. Deng, N. Feeney, N. Tanimine, A. G. Cuenca, S. Deng, J. F. Markmann

  • Transcriptomic Profiling of Paired Serum and Biopsy Samples from FSGS Patients

    C. Kuscu1, M. Kiran2, A. Wolen1, C. Kuscu1, A. Bajwa1, J. Eason1, D. Maluf1, E. Akalin3, V. Mas1

  • TRANSFORM Study (NCT01950819): Application of the Ibox Clinical Trial Simulation Tool to Project Long-Term Kidney Allograft Outcome

    G. Divard1, O. Aubert1, M. Raynaud1, J. Pascual2, F. Vincenti3, P. Bernhardt4, C. Legendre1, A. Loupy1, .. on behalf of TRANSFORM Investigators5

  • Transient Cd4+ T Cell and Cd20+ B Cell Depletion Leads to Prolonged Pig-To-Primate Kidney Xenograft Survival

    B. P. Lovasik1, A. J. Matar1, D. A. Faber1, D. V. Mathews1, C. Breeden1, S. C. Kim1, A. J. Tector2, A. B. Adams1

  • Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation

    E. Palte1, J. Duong2, H. Remotti3, J. Burt3, A. Griesemer4, B. Samstein5, D. Marratta6, A. N. Fox7

  • Transition from Youth to Adult Care of Kidney Transplant Recipients: Single Center Experience

    L. Ganesan, A. McGrath, K. Dahl, K. Dinello, A. Fong, L. Maestretti, M. Patton, P. Grimm, A. Chaudhuri

  • Transitional B Cell Cytokines for the Early Prediction of Long-Term Renal Allograft Decline

    A. Cherukuri1, A. Salama2, A. Sharma1, R. Mehta1, S. Hariharan1, D. Rothstein1

  • Transmission of Synovial Sarcoma by a Single Multiorgan Donor to Three Solid Organ Transplant Recipients

    J. Zhang, J. Lin, Y. Tian

  • Transplant and Cardiovascular Outcomes in Renal Transplant Recipients with Different Pre-Transplant Cardiovascular Risk

    G. Hsu1, T. M. Sparkes1, B. N. Reed2, S. E. Gale1, B. R. Ravichandran1

  • Transplant Center Effect on Acute Liver Failure Outcomes in a National Cohort

    N. Z. Wong, K. R. Reddy, T. Bittermann

  • Transplant Center Experiences with Social Media Campaigns for Living Donation

    S. E. Booker1, L. King2, J. Spiers3, H. Hunt4, R. L. Schaffer5

  • Transplant Monitoring and PTLD Detection with B Cell Receptor Repertoire Analysis in a Large Prospective Pediatric Cohort

    K. Jackson1, O. Martinez2, S. Krams2, M. Robien3, M. Lapasaran2, B. Armstrong4, C. Twist5, K. Weinberg6, D. Gratzinger1, B. Tam1, M. Sever4, M. Brown3, D. Bernstein6, C. Esquivel2, S. D. Boyd1

  • Transplant Outcomes, Risk Factors, and Regional Variation in Selection of Morbidly Obese Liver Transplant Candidates in the US

    T. Lian1, N. Kaur2, J. Emamaullee2, M. Lo3, P. Ender4, J. Kahn5, L. Sher2

  • Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: Update on the Take It Trial

    E. Yoon1, S. Hurr1, L. Curtis1, D. Ladner2, S. Nair3, M. S. Wolf1

  • Transplant Relevant MDSC Genetics: Differential Gene Expression Profiles of Immunosuppressive Myeloid-Derived Suppressor Cells Induced by Granulocyte-Colony Stimulating Factor

    Y. S. Lee, J. S. Bromberg, J. R. Scalea

  • Transplant Surgery Continuing Professional Development Courses Increase Knowledge and Procedural Confidence

    M. J. Hobeika1, T. Menser2, A. Kassam3, T. C. Rice4, T. S. Diwan3

  • Transplantation from Donors with Positive Blood Culture

    H. Mo, S. Min, H. Ko, C. Chung, H. Kim, A. Han, J. Ha

  • Transplantation of HCV Positive Kidneys Confers Excellent Outcomes for HCV Infected and Uninfected Recipients

    J. Torabi, N. Muhdi, A. Montal, J. Melvin, Y. Miura, J. P. Rocca, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, O. Alani, E. Akalin, S. Greenstein, M. Kinkhabwala, J. A. Graham

  • Transplanting Livers from Hepatitis C Virus Positive Donors; Is it Worth the Risk?

    J. W. Mensink1, B. Van Hoek2, B. Schaefer3, M. D. Van Rosmalen4, I. P. Alwayn5, A. E. Braat5

  • Transpulmonary Gradient as a Predictor for Outcomes after Single Lung Transplantation in Patients with Pulmonary Hypertension

    A. Madde1, E. Chan2, J. Ryan2, P. Reck Dos Santos2, M. Morrell3, J. Luketich2, P. Sanchez2

  • Traveling For Transplant: A Comparison of Singly Listed, Multiply Listed, and Non-Citizen Non-Resident Liver Transplant Candidates

    H. J. Braun1, D. Amara1, A. Shui1, C. Huang1, P. G. Stock1, R. Hirose1, F. L. Delmonico2, N. L. Ascher1

  • Treatment of BK Viremia in Kidney Transplant Recipients: A Single-Center Experience

    M. Chaung, E. Hollinger, M. Brokhof, N. Kenyon, L. Lineberger, N. Alvey

  • Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients is Associated with Increased Risk of Urinary Tract Infections and Pneumonia

    E. Joachim, S. Parajuli, K. Swanson, F. Aziz, N. Garg, M. Mohamed, D. Mandelbrot, A. Djamali

  • Treatment of De Novo Renal Transplant Recipients with Calcineurin Inhibitor (CNI)-Free, Belatacept+Everolimus-Based Immunosuppression

    V. R. Peddi1, B. Marder2, L. Gaite3, J. Oberholzer4, R. Goldberg5, T. Pearson6, H. Yang7, L. Allamassey8, S. Gao8, M. Polinsky8, R. N. Formica9

  • Treatment of Hepatic Encephalopathy in Cirrhotic Patients: Does Rifaximin Prevent Clostridioides Difficile Infection? A Retrospective Analysis

    J. D. Goldman, V. Aleksenko, J. L. Davila, N. A. Muhktar, K. Kowdley

  • Treatment Strategies to Suppress Donor Specific Antibodies: Highlights from a Decade of Research Experience in a Mouse Model of Allo-Sensitization

    I. Kim, G. Wu, N. Chai, T. Brennan, A. Klein, S. Jordan

  • Treg Lymphotoxin Signals Promote Cancer Metastatic Migration: Mechanisms for Treg-Cancer Interaction

    W. Piao1, R. Oakes2, C. Paluskievicz1, Y. Xiong1, L. Li1, V. Saxena1, M. WillsonShirkey1, C. Jewell2, J. Bromberg1

  • Treg Protection of the Allograft Depends on Lymphotoxin Beta Receptor Expression in Lymphatic Endothelial Cells

    V. Saxena1, W. Piao1, L. Li1, Y. Xiong1, C. Palusckievicz1, T. Simon1, M. Shirkey1, R. Abdi2, J. S. Bromberg1

  • Treg Stability Depends on Lymphotoxin Beta Receptor-Driven Migration

    V. Saxena, W. Piao, L. Li, Y. Xiong, C. Palusckievicz, T. Simon, M. Shirkey, R. Abdi, J. S. Bromberg

  • Treg Use PD-1 for Lymphatic Migration

    W. Piao1, L. Li1, K. Hippen2, Y. Zhang3, Y. Xiong1, V. Saxena1, C. Paluskievicz1, M. WillsonShirkey1, B. Blazar4, L. Riella5, J. Bromberg6

  • Treg-Lymphatic Interfaces: Unique Molecular Structures for Cell-Cell Interactions During Migration

    C. M. Paluskievicz, W. Piao, Y. Xiong, J. S. Bromberg

  • Trends in Intestinal and Multivisceral Transplantation in the United States over 30 Years

    M. L. Samoylova1, J. Yerxa1, B. I. Shaw1, S. Horslen2, S. Jafri3, A. Mavis4, T. Schiano5, B. Summers6, A. S. Barbas1, D. L. Sudan1, M. C. Segovia4

  • Trends in Liver Transplantation in Patients with Renal Failure Since Implementation of Simultaneous Liver-Kidney Allocation Policy

    P. J. Altshuler, O. Shaheen, A. P. Shah, J. Glorioso, A. Frank, C. Ramirez, W. Maley, A. S. Bodzin

  • Trends in Living Kidney Donation in the United States

    A. Ferzola, Y. Yu, A. B. Massie, D. L. Segev, M. L. Henderson

  • Trends in Time to Graft Loss by Dialysis Vintage

    P. Ahearn, C. Lenihan, J. Scandling

  • Trends in Transplant Center Responses to the Minimum Acceptance Criteria Across UNOS Regions, 2007-2019

    E. M. Roth1, Q. Yuan2, N. Elias2

  • Treprostinil is Safe and Potentially Useful in Preventing Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients

    R. Venkataramanan1, I. H. Shaik2, V. C. Pillai3, O. A. Almazroo4, M. K. Miah5, R. Xu2, S. Dharmayan2, A. Al-Khafaji2, S. Ganesh2, M. Molinari2, A. Tevar2, C. Hughes2, A. Humar2

  • Trough Level Compliance in Immunosuppression is Important to Protect Renal Function after Liver Transplantation – An Additional Analysis from the Hephaistos Study

    P. Schemmer1, F. Braun1, H. J. Schlitt1, A. Pascher1, C. G. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, B. Nashan1

  • Trust and Transparency in Artificial Intelligence-Aided Immunosuppression Decisions

    J. Clement

  • Tumor of Transplanted Kidney: Graft Resection Preserves Renal Function with Good Long-Term Oncologic Outcome

    J. Chlupac, T. Marada, M. Kudla, L. Janousek, J. Fronek

  • Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis

    S. A. Mehta1, A. Katz2, R. Dieter2, P. Jen2, J. Siegfried2, J. Papadopoulos2, T. Lewis2

  • Twin Pregnancies after Liver Transplantation

    L. A. Coscia1, A. Yusuf1, S. Rao2, S. Constantinescu3, M. J. Moritz4

  • Two Novel Methods to Establish Rat Kidney Transplantation Model

    M. Zheng, Z. Gui, Z. Wang, J. Wei, X. Ju, R. Tan, M. Gu

  • Two Pilot Studies Exploring the Diagnostic and Predictive Potential of Serum LAG3 and FGL1 in Kidney Transplant Recipients

    Y. Li1, L. Yan1, Y. Li1, C. Yang1, Z. Wan1, Y. An1, Y. Bai1, L. Wang1, Y. Shi2

  • Two-Year Post-Transplant eGFR as a Surrogate Outcome of Allograft Survival in Kidney Transplant Recipients

    S. Yu, E. Lee, W. Zhang, D. Segev, J. Garonzik-Wang, A. Massie

  • Type 1 Innate Lymphoid Cells Are Critical Pro-Inflammatory Effector Cells in a Fatty Liver Mouse Model of Ischemia-Reperfusion Injury

    J. Kang, K. Loh, J. Green, M. Sadat, M. Stovroff, A. Duttargi, B. Kallakury, K. Khan, T. Fishbein, A. Kroemer

  • Type 3 Innate Lymphoid Cells Are Associated with a Successful Intestinal Transplant

    J. Kang1, K. Loh1, L. Belyayev1, S. Moturi1, M. Sadat1, K. Khan1, A. Duttargi1, Y. Gusev2, K. Bhuvaneshwar2, H. Ressom2, J. Hawksworth1, C. Matsumoto1, T. Fishbein1, A. Kroemer1

  • Tyrosine Receptor Kinase Axl Regulates Intragraft Trafficking of Alloreactive T Cells Post Kidney Transplantation

    A. Dangi1, K. Glinton2, M. Sharma1, S. Yu1, M. DeBerge2, E. B. Thorp2, X. Luo1

Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences